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Abstract: Early onset sepsis is one of the leading causes of neonatal death – worldwide as well as in
high-resource countries (1). The incidence (2) of early-onset sepsis and the case fatality rate (3) are
even higher among preterm infants, in whom a shift towards gram-negative bacteria, predominantly
Escherichia coli, occurs (4). For life-threatening diseases, empiric antibiotic therapy regimens must cover
the most relevant pathogens and, at the same time, avoid any unnecessary use of reserve antibiotics (5,
6). In most cases of early-onset neonatal sepsis, the pathogens colonizing the neonate or its previous
environment, the mother’s womb, are not known when treatment is initiated.
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Early onset sepsis is one of the leading causes of neo-
natal death – worldwide as well as in high-resource 
countries (1). The incidence (2) of early-onset sepsis 
and the case fatality rate (3) are even higher among 
preterm infants, in whom a shift towards gram-nega-
tive bacteria, predominantly Escherichia coli, occurs 
(4). For life-threatening diseases, empiric antibio-
tic therapy regimens must cover the most relevant 
pathogens and, at the same time, avoid any unneces-
sary use of reserve antibiotics (5, 6). In most cases of 
early-onset neonatal sepsis, the pathogens colonizing 
the neonate or its previous environment, the mother’s 





This male preterm infant was born to a 25-year-old 
G1 /  P1 at 27 5/7 weeks of gestation with a birth 
weight of 1060 g (P 25 – 50), a body length of 38 cm 
(P 50 – 75) and a head circumference of 27 cm (P 
50 – 75). The pregnancy had been uneventful until 26 
weeks, when the mother was hospitalized secondary 
to contractions. A complete course of antenatal 
corticosteroids was administered. At 27 2/7 weeks, 
premature preterm rupture of the membranes (PPROM) 
occurred. A vaginal swab revealed gram-positive 
cocci and gram-negative rods. Beta-hemolytic strep-
to coccus group C/G could be cultivated in addition to 
undifferentiated vaginal flora. In addition to tocoly-
tic therapy with hexoprenaline, erythromycin 500 mg 
twice daily was administered until Cesarean section 
became necessary due to contractions refractory to esca-
lating tocolysis and signs of amniotic infection syndrome.
The Apgar scores were 8, 9 and 9 at 1, 5 and 10 
minutes, respectively. Non-invasive respiratory support 
was started (CPAP at 8 cmH2O, FiO2 0.23). An empi-
ric regimen for early-onset sepsis with amoxicillin and 
gentamicin was initiated in the delivery room taking 
into consideration the available microbiological results 
of the maternal swab.
In the neonatal intensive care unit (NICU), respiratory 
distress and desaturations occurred, requiring mecha-
nical ventilation and administration of surfactant on 
the first day of life (DOL). Arterial hypotension was 
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managed with fluid boluses. Interleukin-6 from cord 
blood was slightly elevated (201 ng/ l), while C-reactive 
protein (CRP) was within normal range (1 mg/ l). With 
a time to positivity of 6 hours, aerobic blood culture, 
collected prior to the administration of antibiotics, 
turned positive with pan-sensitive Escherichia coli 
(E. coli). Routine screening with nasal, pharyngeal, 
perianal, umbilical, and tracheal swabs was completed 
on admission to the NICU. Prior to extubation on 
DOL 2, a lumbar puncture was performed and yielded 
no evidence of meningitis (9 cells/µl, negative gram 
stain). Therefore, the empiric antibiotic regimen was 
continued at non-meningitic doses.
On DOL 3, prolonged capillary refill time and peri-
pheral hypothermia were noted. An echocardiogram 
revealed reduced myocardial contractility, near-systemic 
pulmonary hypertension and a hemodynamically rele-
vant persistent ductus arteriosus (PDA). Dobutamine 
was administered at 15 µg/kg/min. The baby remained 
stable on CPAP with an FiO2 of 0.21. 
Later that day, however, blood gases deteriorated with 
marked metabolic acidosis (pH 6.9, lactate 13 mmol/ l, 
and base excess -19 mmol/ l). At this time, the medi-
cal chart was reviewed again. It was noted that the 
routine skin swab obtained as part of routine micro-
biological surveillance had revealed growth of an E. 
coli, still multi-sensitive but resistant to the admini-
stered antibiotic regimen of amoxicillin and gentamicin.
Source Date of collection 
Specimen
Pathogen Resistance to  









Infant Aug 14 umbilical / 
perianal swab












Aug 15 tracheal 
aspirate
E. coli (2) yes Aug 17 
15:00





Unfortunately, the results of the routine skin swab 
had not been recognized in time but only with a 
delay of 6 hours. Consequently, antibiotics were then 
switched from amoxicillin to piperacillin-tazobac-
tam after retrieval of another aerobic blood culture. 
This blood culture confirmed the same E. coli with 
a resistance pattern as documented in the skin swab.
Regrettably, despite change of antibiotics and esca-
lation to maximum intensive care measures including 
high frequency oscillatory ventilation, adrenalin, 
noradrenalin and milrinone, the patient developed 
refractory septic shock (Fig. 1), necrotizing enteroco-
litis, intraventricular hemorrhage, seizures, and died 
on DOL 5 despite ongoing intensive care therapy. 
In the aftermath, the histological report of the 
placenta confirmed acute chorioamnionitis.
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Babygram following intubation under conventional 
ventilation (SIMV, PIP 25 cmH2O, PEEP 8 cmH2O, FiO2 




DISCUSSION Almost 20 years ago, the “Tarragona Strategy” was 
published, addressing ineffective as well as unne-
cessary antibiotic therapy of ventilator-associated 
pneumonia (7, 8). Since then, five key principles of 
the Tarragona Strategy have been applied to antibiotic 
therapy in intensive care services in general (9):
• Look at your patient
• Listen to your hospital (the patient’s environment)
• Hit hard (and early)
• Get to the point
• Focus, focus, focus
 
Although our local guidelines for diagnosis and 
management of early- and late-onset neonatal sepsis 
follow these principles, they failed to prevent the fatal 
course in this particular case. Thus, it is important 
to learn from this situation, to analyze the process, 
and to develop future strategies for the prevention of 
similar events.
In reviewing this case, the following questions arose:
• Was the timing of the Cesarean section the most 
appropriate?
• Could the resistant bacteria in the mother have 
been detected earlier?
• Was the first line antibiotic regimen appropriate?
• Was the management to detect clinical deterio-
ration under therapy appropriate?
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• Was the process of reporting available information 
in a timely manner appropriate?
 
Retrospectively, the answer to the first question is 
„no“, it should have been done earlier in order to 
avoid chorio amnionitis; however, prospective decision-
making is challenging. Every additional day of prolon-
gation of pregnancy from the limit of viability to the 
end of prematurity is beneficial, except for the one day, 
when chorioamnionitis develops and pathogens reach 
the fetus. There is no international consensus about 
the indication, optimal and maximal duration of toco-
lysis in preterm labor, and guidelines and current prac-
tice at times disagree (10 – 12). While there is a strong 
consensus to administer tocolytics until the comple-
tion of antenatal corticosteroid administration, there 
is no proof for the effectiveness of prolonging preg-
nancy until 34 or even 37 weeks of gestation. Clinical 
experience, however, demonstrates, that in the 
absence of contraindications, prolonging tocolysis 
beyond 48 hours is common and, in certain cases, 
appears to prolong gestation (13). Maintaining tocoly-
tic therapy in the presence of PPROM, however, is even 
more controversial because of an increased incidence 
of amniotic infection syndrome. There is a strong con-
sensus that intrauterine inflammation or infection is a 
contraindication for prolongation of pregnancy and 
that timely delivery is indicated in such cases (14). Of 
course, the challenge is the recognition of reliable 
evidence of intrauterine infection. There are efforts 
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to unify definitions and thereby simplify management 
strategies, but still, uncertainties prevail (15). For these 
situations, each institution should develop clinical 
management guidelines that are applicable 24 hours 
a day to facilitate decision-making (“Look at your 
patient”). 
Could the resistant bacteria in the mother have been 
detected earlier? Possibly, yes, if the microscopically 
detected gram-negative rods had been differentia-
ted (“Look at your patient” and “Listen to your hos-
pital”). The current aim of vaginal swabs in PPROM 
is to guide antibiotic therapy of the mother. If these 
vaginal swabs, however, would be regarded as coloni-
zation screening of the newborn-to-be, it would need 
cultural differentiation and determination of resi-
stances of all pathogens, similar to what is performed 
in neonatal colonization screening after birth (16 – 18). 
Knowing the bacteria colonizing a patient should not 
only increase the rate of appropriate antibiotic the-
rapies but also reduce the use of unnecessary broad-
spectrum antibiotics (“Focus, Focus, Focus”). Colo-
nization should, however, never trigger antibiotic 
therapy in the absence of an infection.
Was the first line antibiotic regimen appropriate? 
In our hospital, based on the annual analysis of 
resistances of the specimens collected in the whole 
hospital, the intensive care units, and the neonatal 
department, about 7 – 8 % of all isolated E. coli are 
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resistant to gentamicin (“Listen to your hospital”). All 
isolates resistant to gentamicin are also resistant to 
amoxicillin. For patients infected by these isolates, our 
initial regimen will be ineffective. E. coli accounts for 
about one quarter of all cases of early-onset sepsis 
(19), in preterm infants the incidence is somewhat 
higher (20). Many infants receive empiric antibiotic 
treatment without fulfilling the full criteria of early 
onset sepsis. Therefore, the number-needed-to-treat 
with an alternative (broader) regimen in order to 
achieve one additional effective treatment would be 
clearly higher than 100 patients – which seems inap-
propriate to us. We believe, it is more appropriate to 
ensure awareness of this gap in antibiotic effective-
ness among our staff and make sure that second line 
treatment is initiated in a timely manner in case of 
clinical non-response to the first line treatment (“Look 
at your patient” and “Hit hard”).
Was the management to detect clinical deteriora-
tion under therapy appropriate? In this case, it was 
obviously not: clinical deterioration on DOL 3 was 
apparent many hours before antibiotics were chan-
ged. Gradients of peripheral-to-core-temperature, 
reduced stability to nursing procedures and cardiac 
dysfunction were recognized many hours prior to 
the recognition that the antibiotic treatment was 
ineffective. Analysis of C-reactive protein 48 hours 
after initiation of therapy showed only a slight eleva-
tion (13 mg/ l), the results of the initial blood culture 
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suggested appropriate choice of antibiotics. Finally, 
the rareness of colonization (and even more: infec-
tion) with two different strains of the same pathogen 
likely contributed to misinterpretation of the new 
symptoms. This type of error, namely assuming that 
the infection is treated with the correct antibiotics 
and therefore under control, neglecting the possibi-
lity of a “second hit infection”, is known as „fixation 
error“. It can be overcome by strategies described in 
Crew Resource Management, e.g. stepping back and 
re-evaluating the situation (“10 for 10” principle in 
CRM (21)). 
Was the process of reporting available information 
in a timely manner appropriate? The answer is „no“. 
The system of microbiological surveillance had just 
been implemented in routine clinical practice. Several 
factors may have contributed to this failure: 1) The 
initial detection of the second strain of E. coli came 
from a skin swab (and not from sterile material); 2) the 
strain was not multi-resistant but “only” resistant to 
gentamicin and amoxicillin; 3) results were not com-
municated by phone due to perceived lack of urgency 
by the microbiologist; 4) the patient initially improved. 
Since then, this case has become a “teaching case” 
and is used on a regular basis to teach how to use and 
interpret the findings of the microbiologic surveillance 
system – hoping to prevent a re-occurrence of such a 
course.
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One question remaining unanswered is the origin 
of the second strain of E. coli. It seems very unlikely 
that aminoglycoside resistance could have develo-
ped within two days under the pressure of antibiotic 
therapy. Most likely, it was present in the mother 
together with the pan-sensitive first strain, but it is 
also possible that the second strain was only trans-
ferred after birth. The first strain may have facilitated 
bloodstream invasion of the second strain.
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